How to Identify, Treat, and Manage Patients with Multiple Myeloma
ASH 2021: Genomic and Immune Signatures Predict Sustained MRD Negativity in NDMM Patients Treated with D-KRd
By
ASH 2021 Conference Coverage on VuMedi
FEATURING
Eileen Boyle
By
ASH 2021 Conference Coverage on VuMedi
FEATURING
Eileen Boyle
Login to view comments.
Click here to Login
How to Identify, Treat, and Manage Patients with Multiple Myeloma